The DGLP MEDICINE 04 tender, identified by reference number 169538e2d, is officially issued by the Department of Military Affairs under the Ministry of Defence. This tender primarily focuses on the procurement of essential pharmaceuticals, specifically concentrations of Artemether 80 mg plus Lumefantrine 480 mg Tabs, Artesunate 60 mg Inj, and Beclomethasone Dipropionate 200 mcg metered doses.
Scope of Work and Objectives
The primary objective of the DGLP MEDICINE 04 tender is to ensure a streamlined supply chain of critical medications required by military health services. This tender includes the procurement of 9,925 units of medicines divided among the specified categories to maintain adequate health resources within military establishments and ensure the wellbeing of personnel.
Eligibility Criteria
To qualify for participation in this tender, bidders must meet certain eligibility criteria, including being a registered supplier of pharmaceutical products. Companies must demonstrate adequate experience in pharmaceutical manufacturing and supply, possess valid licenses for drug distribution, and comply with industry regulations.
Technical Requirements
The products provided under this tender must comply with rigorous technical specifications and quality standards to ensure safety and effectiveness. Bidders are required to submit product specifications, manufacturing process documentation, and performance data to substantiate their compliance with applicable standards.
Financial Requirements
Bidders must provide financial documents including proof of capability to fulfill the contract, bank statements, and any other financial guarantees required as part of the submission process. The financial health and stability of the bidding companies will be evaluated during the tender assessment.
Document Submission Details
Interested parties must ensure that all necessary documents are submitted according to specified submission methods. The bidding documentation should include technical proposals, financial statements, and any certifications pertinent to the pharmaceuticals offered. The submission formats accepted include digital documents in PDF and Word formats.
Special Provisions
The tender encourages participation from Micro, Small, and Medium Enterprises (MSEs) and startups. Special provisions may be in place to support these entities, including reduced financial barriers. This aligns with governmental initiatives aimed at promoting local enterprises and supporting entrepreneurial growth.
Evaluation Process
The evaluation and selection process for this tender will consist of a thorough assessment of the received bids based on compliance with eligibility and technical criteria, quality standards, and cost-effectiveness. Price evaluation will be conducted taking into account the overall value offered by the bidder. The results of the evaluation will be communicated to all participants promptly.
Delivery Locations
The required medicines are expected to be delivered to designated military healthcare facilities, with specific addresses provided upon successful bid acceptance. Companies should ensure that their logistics capabilities align with the delivery requirements specified in the tender.
Contact Information
For further inquiries related to this tender, potential bidders may seek clarification through the channels provided with the tender documentation. Direct contact details are typically included for the department or officials responsible for managing the tender.
This tender represents an opportunity for established and emerging pharmaceutical entities to contribute to military healthcare efforts by providing critical medicinal support. Bidders are encouraged to prepare comprehensive proposals that meet all outlined requirements to ensure successful participation in the procurement process.
Tender BOQ Items
11 ItemsGeneral Information
Financial Information
Evaluation and Technical Information
Tender Documents
4 DocumentsSimilar Tenders
Frequently Asked Questions
The eligibility requirements include being a registered entity within the pharmaceutical sector, maintaining valid licenses for drug distribution, and having experience in manufacturing similar health products. Bidders must also comply with industry regulations to ensure the safety and efficacy of the medicines they offer.
All products submitted must conform to strict technical specifications and quality standards as outlined in the tender documentation. This includes verification of the manufacturing processes, adherence to safety protocols, and compliance with health regulations to ensure that all medications are effective and safe for military use.
Document submissions for the DGLP MEDICINE 04 tender must be made digitally. Accepted document formats typically include PDF and Word files. Bidders must ensure that all documentation is complete and adheres to the specified guidelines in the tender to avoid disqualification.
Bidders must provide details about payment terms during the submission process. Typically, performance security is set as a percentage of the contract value and must be furnished to ensure compliance with contract obligations and timely delivery of products.
Micro, Small, and Medium Enterprises (MSEs) can access special provisions in this tender that aim to reduce financial barriers for participation. These benefits may include simplified bidding processes, reduced performance securities, and active encouragement from the government to support local manufacturing endeavors aligned with national policies such as Make in India.
Probable Bidders
Get Tender Alerts
Get notifications for similar tenders